| Title |
A case–control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events
|
|---|---|
| Published in |
Clinical Rheumatology, December 2014
|
| DOI | 10.1007/s10067-014-2846-1 |
| Pubmed ID | |
| Authors |
David A. Geier, Mark R. Geier |
X Demographics
The data shown below were collected from the profiles of 177 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 44 | 25% |
| India | 6 | 3% |
| United Kingdom | 5 | 3% |
| Colombia | 4 | 2% |
| Japan | 3 | 2% |
| Australia | 3 | 2% |
| Canada | 2 | 1% |
| Netherlands | 2 | 1% |
| Georgia | 2 | 1% |
| Other | 10 | 6% |
| Unknown | 96 | 54% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 152 | 86% |
| Practitioners (doctors, other healthcare professionals) | 15 | 8% |
| Scientists | 7 | 4% |
| Science communicators (journalists, bloggers, editors) | 3 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 99 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 1% |
| Colombia | 1 | 1% |
| Unknown | 97 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 23 | 23% |
| Researcher | 14 | 14% |
| Student > Bachelor | 11 | 11% |
| Student > Postgraduate | 10 | 10% |
| Other | 8 | 8% |
| Other | 15 | 15% |
| Unknown | 18 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 50 | 51% |
| Nursing and Health Professions | 6 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
| Biochemistry, Genetics and Molecular Biology | 3 | 3% |
| Immunology and Microbiology | 3 | 3% |
| Other | 10 | 10% |
| Unknown | 24 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 123. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 March 2024.
All research outputs
#346,559
of 25,768,270 outputs
Outputs from Clinical Rheumatology
#20
of 3,314 outputs
Outputs of similar age
#3,905
of 361,431 outputs
Outputs of similar age from Clinical Rheumatology
#1
of 37 outputs
Altmetric has tracked 25,768,270 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,314 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,431 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.